3月11日 - ** 癌症疗法生产商传奇生物技术公司LEGN.O股价上涨5.6%，至35.96美元
** 该公司在 (link) 上公布的第四季度每股净亏损为 16 美分，而去年同期为24 美分。
** 截至 2024 年 12 月 31 日，公司拥有 11 亿美元的现金及现金等价物和定期存款，公司认为这将为 2026 年第二季度提供资金支持。
** 在过去 12 个月中，LEGN 下跌了 46.1
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.